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Connective tissue diseases (CTD) and systemic vasculitis impact on health-related quality of life. 
Treatment can be complex involving multiple medical specialities. This study’s aim was to investigate 
psychological and self-management support for patients in secondary care. 
Methods  
Online survey of health professionals in the UK including 45 multiple-choice and free-text questions 
analysed descriptively. Free-text survey responses were analysed thematically to identify health 
professionals’ perceptions of best practice and unmet needs. 
Results 
Online survey included 120 health professionals (34% specialist nurses, 51% doctors, 12% allied 
health professionals), predominantly working in rheumatology (52.9%) and nephrology (21.5%) 
departments. Access to self-management programmes or clinics for people with CTD or vasculitis 
was available in 23% of rheumatology and 8% of nephrology departments. In response to “How well 
is your team providing self-management support to people with CTD or vasculitis?”, 38% of 
respondents reported “not very well” or “not well at all”. Direct access to psychological support was 
available in 76.9% nephrology and 32.8% rheumatology departments. Over 80% of respondents 
would like additional training.  Key themes from the qualitative data (free-text survey responses) 
included importance of: dedicated psychological support and self-management programmes for 
people with CTD and vasculitis, whole team approach (specialist teams empowering people to 
manage their own care), staff training (e.g. brief psychological interventions) and signposting to 
resources including patient charities.   
Conclusion 
People with CTD and vasculitis have complex needs and improvements in self-management and 
psychological support are required in UK rheumatology and nephrology departments.    
 
Key Messages: 
1. Connective tissue diseases (CTDs) and systemic vasculitis impact on peoples’ health-related 
quality of life.  
2. Two thirds of rheumatology professionals report no psychological support available for people 
with CTD/vasculitis. 
3. Eighty percent of health professionals report no self-management support available for people 
with CTD/vasculitis. 
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The rare autoimmune rheumatic diseases include the systemic vasculitides (e.g. ANCA associated 
Vasculitis (AAV), Behcets disease, polyarteritis nodosa, Takayasu arteritis and giant cell arteritis) and 
the connective tissue diseases (CTD, e.g. systematic lupus erythematosus (Lupus), inflammatory 
muscle diseases, systemic sclerosis, antiphospholipid disease and Sjögren’s syndrome).1   
 
People with CTD and vasculitis present with multi-organ disease which can require complex 
treatment regimens including glucocorticoids, chemotherapy, and biological medications; many of 
these therapies can cause significant morbidity to patients.2-4  These diseases can be life and organ 
threatening; 25% of patients with AAV will die within 5 years of diagnosis,5 a higher proportion than 
that seen with breast and prostate cancer. Care is usually led by rheumatology or nephrology teams 
but a range of medical and surgical specialists can be involved depending on the nature of the 
person’s specific disease.6 The care available to people with CTD and vasculitis is often fragmented 
across different medical specialities and hospitals,  and people can find it difficult to navigating the 
healthcare system.7 The impact of fatigue is consistently ranked as a key aspect of health-related 
quality of life in people with CTD or vasculitis. 8-11 Having a rare autoimmune disease can also be 
isolating;12 13 family, friends and health care professionals can lack detailed knowledge and 
understanding 14.  These factors can contribute to the high levels of distress seen in this group of 
patients.15 16 The Rare Autoimmune Rheumatic Disease Alliance (RAIRDA) UK survey (n=2000) of 
people with Lupus, scleroderma and vasculitis highlighted that 61% struggle to cope with their 
condition.14 
 
Lorig17 conceptualised self-management as three aspects of management that patients must address 
when dealing with having a chronic disease: medical (e.g. interacting with healthcare professionals, 
adhering to medications); role (e.g. adapting to changes in relationships and social roles); and 
emotional (e.g. processing negative emotions such as anger and anxiety). A Europe-wide survey 
(EURODIS) found that 42% of people who live with rare diseases spend more than 2 hours a day in 
tasks related to their illness, while 25% spend more than 6 hours.18 The need for better patient 
support to manage their own care and navigate through complex care pathways are key 
recommendations from the 2013 Department of Health Strategy for Rare Diseases and the 2014 
British Society of Rheumatology Workshop on autoimmune rheumatic diseases.19 20 The NHS 5-year 
forward plan also highlights self-management as a key element in the care of patients with long-
term conditions21. 
 
Psychological need can be conceptualised as a pyramid; the majority of people will have lower levels 
of need, whilst a smaller proportion will have greater needs, as represented by the top of the 
pyramid7.  For many patients who have psychological symptoms, self-management programmes can 
provide information about their condition and coping strategies to help with anxiety, depressive 
symptoms and disease activity. 22-24 25  Those with more severe emotional or mental health problems 
require specialist psychological interventions, that take account of their physical health status.7 18   
 
The RAIRDA and EURODIS surveys 14 18 have highlighted the range of unmet needs of importance to 
people with CTD and vasculitis, including peoples’ views on what their support needs are from 
health professionals. 
The aims of the present study were to: 
  
1. identify health professionals’ perceptions of the presence and quality of self-management 
and psychological support available to people with CTD and vasculitis in secondary care in 
the UK 
2. explore best practice and potential improvements in terms of self-management and 
psychological support for people with CTD and vasculitis 
3. explore the training needs of health-professionals in terms of self-management and 




This project comprised an online cross-sectional survey including closed and short-answer questions. 
The survey was designed by the steering committee (including health professionals from 
rheumatology and nephrology, researchers and methodologists) and piloted by rheumatology 
specialist nurses and clinicians at the Bristol Royal Infirmary.   
The study was given ethical approval by the Faculty Research Ethics Committee at UWE Bristol 
(Reference: HAS.19.03.152). Participants were informed that by completing and submitting the 
online survey they were giving their implied consent. No personally identifiable data was used, 
although to enable late withdrawal requests, the online system randomly assigned an identifier to 
each participant, which they were asked to quote if they wished to withdraw.  
Participants  
Health professionals (including specialist nurses, clinicians, allied health professionals (AHPs), 
psychologists and pharmacists) working with people living with CTD or vasculitis in secondary care in 
the UK were invited to participate in the online cross-sectional survey. 
The Survey  
The survey questionnaire was developed in Qualtricsxm26, an online survey platform which enables 
survey construction and hosting of the data on secure servers during data collection.  The survey 
comprised 45 items including multiple choice response and open-ended questions.  The regional 
location was compulsory in order to ensure that the response was limited to UK-based staff.  The 
items were divided into three sections: i) Participant demographics, including professional 
background, experience and geographical region; ii) Questions related to self-management support 
for people with CTD and vasculitis in their service; and iii) Questions related to psychological support 
for people with CTD and vasculitis in their service.  
During the online survey, participants were shown the definition of self-management as defined by 
Lorig,17 (i.e. the medical, role and emotional management required of people when adapting to a 
chronic disease) to refer to when answering questions related to self-management.   
Items on the team’s ability to provide self-management and psychological support services were 
designed as five-point Likert scales ranging from ‘Extremely well’ to ‘Not well at all’.  Participants 
were also asked to rate their own confidence in providing self-management support and in 
recognising a patient’s need for psychological support (four-point scale, from ‘completely confident’ 
to ‘not at all confident’). 
  
Seven free text, open-ended questions were used to explore current provision and best practice and 
potential improvements identified by health professionals working with people with CTD and 
vasculitis. These included questions about current self-management clinics or programmes for 
people with CTD or vasculitis held in their department; what worked well and what could be 
improved; what was available in terms of psychological support, including what was good about the 
support and what could be improved, and what are the training needs for staff in terms of self-
management and psychological support for people with CTD and vasculitis.   
Data collection procedures 
Health professionals from different medical specialities (particularly rheumatology and nephrology), 
professional background, geographical regions, and type of hospital setting (district general hospitals 
(DGHs) and NHS England Specialist Centres were actively targeted to ensure a broad representation 
of experiences and views).  
Participants were recruited via social media with the post: “Are you a nurse, doctor, AHP or 
psychologist who has ever worked with people with Vasculitis or CTD? Please complete our quick 
survey of psych and self-management support in the UK. Interested in renal/rheum/DGH or 
specialist opinions”. A link was provided to the Qualtrics survey26.  The post was tweeted via the 
study account (@SelfSurvey), the British Society of Rheumatology account (@RheumatologyUK), 
posted on the Royal College of Nursing Rheumatology nursing forum and distributed via the United 
Kingdom and Ireland Vasculitis Registry (UKIVAS) and UK GCA Consortium email lists. The survey was 
also advertised during a talk at the British Society for Rheumatology Conference, 201927.  
Data analysis:  
For statistical analysis the following combined items were defined: ‘Doctors’ combined ‘Consultants’ 
and ‘Registrars’; ‘Nurses’ combining ‘Advanced Nurse Practitioners’, ‘Nurse specialists’ and ‘Staff 
Nurses’.  ‘Allied Health Professionals’ were also defined as including ‘Occupational Therapists’, 
‘Physiotherapists’, ‘Pharmacists’ and ‘Podiatrists’. 
Analysis of survey data was initially undertaken within Qualtricsxm26, with further analyses in IBM 
SPSS for Windows (Version 25.0. Armonk, NY: IBM Corp). Data were summarised and analysed 
descriptively, categorical data presented as proportions.  Contingency tables with Χ2 statistics were 
used to test the significance of the association between categorical variables. Where appropriate, 
odds ratios (OR) were calculated to quantify the magnitude of the association28.  Analysis of the 
Likert Scale questions used the Kruskal-Wallis test29 to assess differences between groups. 
Free text survey responses were organised using NVivo v1230 software. A combined inductive and 
deductive approach was used31.  Themes of importance were identified by three independent 
researchers (MS, JR and KA), including key elements of good practice, how self-management and 
psychological support could be improved, and health-professional training needs.  The Chronic Care 
Model (CCM)32 was chosen as the framework for the deductive analysis. The CCM is an evidence-
based framework which highlights the key modifiable components of a health care system which can 
support high-quality, patient-centred chronic disease management. The CCM accounts for the many 







Participant characteristics:  
A total of 120 responses were received from the online survey, which was open for six weeks from 
April 16th to May 31st 2019. 
Table 1 describes the professional background and demographic details of the survey participants. 
Most of the health professionals worked in either rheumatology (52.9%) or nephrology (21.5%) 
departments. There was a range of participants with different professional backgrounds (specialist 
nurses, allied health professionals and doctors) and types of hospitals (DGH versus teaching and  
NHS England specialist centres). Most participants (86%) reported that they regularly saw patients 
with CTD or vasculitis. Survey participants were from across the UK although most came from 
English hospitals (supplementary materials 1). 
Who is providing self-management and psychological support for patients with CTD and vasculitis?  
Overall, 18.3% of participants (n=17) reported having self-management clinics (i.e. one to one 
support) or group programmes in their department which included people with CTD and vasculitis 
(14 from rheumatology and 2 from nephrology).  
Health professionals reported that the self-management support currently provided is delivered by 
AHPs (53%), nurses (52.5%), doctors (12.5%) and psychologists (10%).   Differences were seen 
between rheumatology and nephrology departments in terms of who provided self-management 
support, with a higher proportion of nurse specialists and AHPs in rheumatology (Figure 1A). 
Approximately 40% of health professionals were able to provide direct access to psychological 
support for their patients with CTD or vasculitis, either in their department or hospital.  There was 
greater access within nephrology (20/26; 76.9%) compared to rheumatology departments (21/64; 
32.8%) (Χ2=19.10, p<0.001, OR=6.8). Health professionals in nephrology were also more likely to 
have a psychologist in their team (15/26; 57.7%) than in rheumatology departments (14/64; 21.9%), 
(Χ2=13.83, p<0.001, OR=4.9).  Health professionals working in rheumatology departments were more 
likely than those in nephrology departments to rely on indirect referrals for psychological support 
(signposting to general practice or self-referral to community providers) (Χ2=14.93, p=0.001, 
OR=4.82).  See Figure 1B. 
Health professionals’ ratings of self-management support provision for people with CTD and 
vasculitis 
The quality of the self-management support provided was rated by 61.8% of respondents as 
providing support ‘extremely well’, ‘very well’ or ‘quite well’, 38.2% rated their service as providing 
support ‘not very well’ or ‘not well at all’.  There were no differences between those working in 
nephrology and rheumatology (Χ2=0.036, p=0.982), or between those working in DGHs and those in 
teaching hospitals or NHS England specialist centres (Χ2=0.308, p=0.579). There were no differences 
in ratings between the assessments given by doctors (57.1% rated self-management provided ‘quite 
well’ or better), nurses (64.3%) and allied health professionals (57.1%, Χ2 =2.39, p=0.495 see Figure 
2a/2b).   
Health professionals’ ratings of psychological support provision for people with CTD and vasculitis 
Psychological support was assessed as being provided quite well, very well or extremely well 
provided by 53% of those responding overall.  Nephrology staff rated the provision as better, with 
  
77.3% rating their provision as ‘quite well’ or better; 46.6% rheumatology staff gave this rating, 
(Χ2=0.431, p=0.014, OR=3.90). (Figure 2c) 
Where referrals were direct, within the department itself, within the hospital or directly to 
psychologists or counsellors in the community, more respondents (31/42, 73.8%) rated the quality of 
the service as higher (“well” or “extremely well” provided) than respondents ( 14/42, 33.3%) in 
departments where the referrals were indirect (Χ2=13.832, p<0.001, OR=5.6). 
Health professionals from DGHs assessed their psychological support as ‘not very well’ or ‘not at all 
well’ provided in (16/22, 72.7%) of cases, compared to (15/40, 37.1%) of those from teaching 
hospitals or NHS England specialist centres (Χ2=8.288, p=0.004, OR=4.4).  There were no significant 
differences between professional groups;  doctors assessed psychological support as being provided 
‘quite well’ or better in 52.1% of cases, nurses assessed support at this level in 53.8% and allied 
health professionals assessed it at this level in 50% (Χ2= 1.82, p=0.611), see also Figure 2d. 
Health professionals’ confidence and training needs  
Self-management support was a role that health professionals undertook regularly (36.5%) or 
occasionally (48.2%), a smaller number of respondents rarely or never (10.9%) provided support.  
Fifty-two percent of nurses, 71.4% of AHPs and 61.2% of doctors said that they felt confident in 
delivering self-management support.  As expected, those who provide self-management support 
‘regularly’ were more likely to be confident in undertaking this task than those who do not do this 
regularly (Χ2=26.0, p<0.001, OR=44.2).   
Over eighty percent of respondents reported that they would like additional training in self-
management support for people with CTD and vasculitis.  Those less confident were more likely to 
see training as a priority (Χ2=4.36, p=0.037, OR=3.9). Free-text responses showed that training might 
include brief psychological interventions, communication skills and how to set up a self-management 
programme (Table 2). 
Most professionals felt that they were confident in recognising patients who would benefit from 
psychological support (76.9% of nurses, 87.5% of AHPs and 79.2% of doctors). 
Analysis of short answer responses 
Responses to individual open-ended questions varied from a single phrase or sentence, to several 
paragraphs, with many of the responses being 3 or 4 sentences for individual questions. Deductive 
analysis using the chronic care model as a reference framework was used to analyse the data across 
responses to these questions. After discussion between the three researchers, 162 references were 
organised into 13 key overarching themes and aligned with one of the six interrelated elements of 
the CCM (Health systems (Table 2), Decision Support, Clinical Information systems, Patient self-
management support, Community resources and Delivery system design (Table 3)). No themes were 
identified in relation to C. Clinical Information Systems. Key themes including the importance of a 
positive departmental ethos towards supporting self-management (particularly in terms of 
investment in training and resources), multiple benefits of having psychological support embedded 
within rheumatology and renal departments, and the importance of multidisciplinary working. 
Developing a self-management programme specifically for people with CTD and vasculitis or sharing 
resources provided to people with other conditions, plus staff training to improve confidence in 







This is the first study to examine provision of self-management and psychological support for people 
with vasculitis and connective tissue disease within secondary care in the UK.  
Over eighty percent of health professionals reported they had no self-management clinics or 
programmes that catered for patients with CTD or vasculitis in their centres; within nephrology this 
rose to over ninety percent. The RAIRDA survey of people with vasculitis and CTDs highlighted that 
60% struggle to cope with their disease and 40% felt that they did not have enough information and 
support from the hospital in living with their condition14.  In this survey, almost the same proportion 
of health professionals (also 40%) felt that self-management was “not provided well” to people with 
CTD and vasculitis in their secondary care departments. These results highlight the unmet needs in 
terms of support for people with rare rheumatic diseases. 
Access to specialist psychological support was identified as a key requirement by health 
professionals in this survey, in the support of people with CTD and vasculitis. This survey 
demonstrates some inequalities in access across secondary care due to location and speciality. 
Direct access to psychological support for patients with vasculitis or CTD was available in almost 80% 
of nephrology departments; but only one third of rheumatology departments. Psychological support 
provision in DGHs was reported as worse, (rated as “not well provided” by 72.7% of health 
professionals in those centres), compared to that available in teaching hospitals and NHS England 
specialist centres, (rated as “not well provided” by 37.1%). Health professionals identified similar 
barriers to providing self-management and psychological support to people with CTD and vasculitis 
(lack of time, skills and management support) as previously highlighted by a survey of psychological 
support provision for people with RA in the UK33.  
The main strength of this survey is the breadth of health professional participants: from a range of 
medical specialties (predominantly rheumatology and nephrology), with a range of professional 
backgrounds (nurses, allied health professionals and doctors), from different types of hospitals 
(teaching, district general and specialist centres for CTD and vasculitis) and geographical regions 
across the UK. This study also used mixed methods, using survey data to gain a breadth of 
perspectives and then short-answer and in-depth interviews to explore topics of greatest interest in 
more depth.  
While online surveys have advantages in terms of cost and timeliness, there are also disadvantages 
in control over samples and selection bias. 34 35  One limitation in this survey is that a higher 
proportion of participants were from rheumatology departments compared to other departments, 
and a higher proportion of renal physicians versus renal nurses were included. This may be due to 
the fact that renal nurses are less likely to see patients with CTD/vasculitis unless they are on 
dialysis, as they do not tend to do outpatient clinics, as opposed to rheumatology specialist nurses 
who may lead or work in parallel with rheumatologists in the outpatient clinics. There was also a 
higher proportion of allied health professionals working within rheumatology, as would be expected 
for a speciality focused on MSK conditions.   
The biggest limitation to this survey, is that it is likely to have been completed by health 
professionals with an interest in these topics, therefore the survey may not capture the full breadth 
of views and experiences. However, 80% of health professionals were keen to receive further 
training specific to self-management in CTD and vasculitis. There were also a higher proportion of 
  
respondents from teaching hospitals/ specialist CTD or vasculitis centres than DGHs. Specialist 
centres may potentially benefit from an increase in psychological and self-management provision 
due to having a greater pool of patients with these diseases. The true provision across DGHs across 
the UK may therefore be much lower outside these centres. In order to maintain anonymity, we did 
not record the exact institution each health professional came from; this could be a limitation of the 
survey if more than one respondent came from the same hospital. We did however record 
respondents’ geographical distribution (Supplementary material A).  Respondents were from 9 
different English regions, plus Wales, Northern Ireland and Scotland and this supports the 
generalisability of the findings across the UK. 
 
Management guidelines for treatment of people with CTDs and vasculitis focus mainly on treatment 
of physical symptoms, although patient education and care within a wider multidisciplinary team are 
also highlighted2 36-39. This survey demonstrates the range of health professionals who are currently 
delivering self-management support for people with CTDs and vasculitis in the UK, primarily within 
individual clinic appointment settings. Evidence from studies in Lupus and rheumatoid arthritis (RA) 
have demonstrated the potential positive impact of self-management programmes on patient 
wellbeing and reduction in resource utilisation. 40-42 17 43 44 Current research studies targeting fatigue 
include a remotely delivered cognitive behavioural and graded exercise programme for people 
across the inflammatory rheumatic diseases45 46 and a disease-specific feasibility study of a combined 
physical activity and behavioural support intervention in AAV.47  
This study highlights a range of proposals on how to improve provision of self-management and 
psychological support, identified by health professionals working with people with CTD and 
vasculitis. These include broadening access to generic self-management courses, developing new 
courses specifically designed for people with CTD or vasculitis; or use of brief psychological 
interventions for use within routine clinic appointments by all health professionals. Development of 
future interventions will need to include all stakeholders including patients, staff and funders. The 
key finding in terms of psychological support is the broad ranging benefits of having an embedded 
psychologist within the clinical team for people with CTD and vasculitis; through contributing to a 
supportive team ethos focused on self-management and psychological support, delivery of specialist 
group and one to one interventions, and practical support and training of the wider multidisciplinary 
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Tables and Figures 
Table 1: Description of online survey participants 
Speciality n (%)    
     Nephrology  26 (21.7%)  
     Rheumatology  64 (53.3%)  
     Other Specialty Research (4)  





9 (7.5%)  
     Specialty not given  21 (17.5%)  
  Rheumatology Nephrology 
Type of hospital n (%)    
     District general hospital   19 (30.2%) 3 (11.5%) 
     Teaching hospital  23 (36.5%) 17 (65.4%) 
     NHS England specialist centre  21 (33.3%) 6 (23.1%) 
    
Professional background n (%)    
  Nurses           Nurse Specialists (31)  
Staff Nurses (2)  
Research Nurses (2) 
Advanced Nurse 
Practitioner (1)       
24 (38.1%) 5 (19.2%) 
Allied Health                                                               
Professionals 
Physiotherapists (4) 
Podiatrists (3)  
Occupational Therapist (3)  
9 (14.3%) 2 (7.7%) 
Doctors Consultants (41)  
Doctor in training (10) 
30 (47.6%) 19 (73.1%) 
Others Psychologists (1) 
Pharmacists (1) 
    
    
Experience in specialty n (%)    
    Under 5 years  8 (12.7%) 5 (19.2%) 
    5 to 10 years  17 (27%) 2 (7.7%) 
    10 to 20 years  23 (36.5%) 10 (38.5%) 
    Over 20 years  15 (23.8%) 9 (34.6%) 
    
Level of experience and interest in working with patients who 
have CTD and Vasculitis n (%) 
  
  Regularly see patients, and 





  Regularly see patients, but not 
a special interest 




  Do not regularly see patients, 
but interested 




  Rarely see patients with CTD or 
vasculitis            




Figure 1 Who is providing self-management and psychological support for people with Systemic 
Vasculitis or Connective Tissue Diseases? 
A. Comparison between health professionals. Other is defined as including podiatrists, pharmacists 
and wellness team. *p<0.05, **p<0.001 
B. Comparison between rheumatology and nephrology departments. Direct access defined as 
psychologist available to patients with CTD or vasculitis within the team or hospital. Indirect access 
to psychologist defined as health professionals either signposting patients back to general 
practitioners or advising self-referral to community providers. *p<0.05, **p<0.001 
 
Figure 2. How well do you think self-management and psychological support is provided in your 
Department?  
A. Comparison between rheumatology and nephrology departments. *p<0.05, **p<0.001 
B. Comparison between rheumatology and nephrology departments. *p<0.05, **p<0.001 
  
Table 2. Key elements of self-management and psychological support for people with CTD and Vasculitis identified by rheumatology and nephrology 
health professionals in the UK. Mapped to the Chronic Care Model (A. Health systems).  











SELF MANAGEMENT SUPPORT FOR PEOPLE WITH CTD AND 
VASCULITIS 
 
Supportive organisational and team ethos is key: 
- Culture of valuing self-management across the whole team 
- Having a well informed and trained MDT to provide 
support 
- Clinical leadership/clinician with a specialist interest in 
CTD/vasculitis 
- Forward looking view of department 
- Good communications between consultants and the MDT 
 
Resources needed to promote self-management: 
- Resources to deliver self-management courses 
- Financial support 
- Adequate staffing 
- Adequate time within clinic appointments 
- Clinic capacity 
- Note that patients and staff can be geographically diverse. 
 
Specific investment in training required: 
- Training in brief interventions to support self-management 
within clinic appointments, e.g. behaviour change 
management 
- Training in management of fatigue and emotional impact 
of CTD and vasculitis 





Examples of facilitators of self-management 
 
- Having resources within the team to be able to deliver the self-
management support, such as time, trained staff, ongoing support in 
the delivery of self-management such as supervision; good referral 
pathways and dissemination of support offered amongst the team so 
that the team is aware of the support and can discuss this with 
patients. A platform from which to let patients know directly about 
the support that is offered so that they can access this themselves. 
(AHP, SW England, Rheumatology) 
 
- Acknowledgment from the whole team that this [self-management] 
is needed and wanted by patients, and an essential part to their 
whole and holistic care. (Specialist Nurse, Nephrology, W Midlands) 
 
 
Barriers to self-management support 
 
- Limited psychology support, no specialist nurse or dedicated clinic.  
These patients are spread through 5 consultants and a geographical 
spread of clinics. (Consultant, SW England, Nephrology)  
 
- Time and staff availability are the main barriers.  We have existing 
self-management group structures and clinical expertise at delivering 
self-management in group format for different conditions that would 
support creation of a self-management programme for vasculitis or 





































PSYCHOLOGICAL SUPPORT FOR PEOPLE WITH CTD AND 
VASCULITIS 
 
Need for clinical psychologists to be embedded within the 
clinical team: 
 
- Support patients with different psychological needs: IAPT 
to full clinical health psychology. 
- Routine psychological support for all people with 
CTD/vasculitis rather than as required 
- Work with MDT in group psychological and self-
management programmes 
- Training and supervision of other health professionals 
within the MDT 
- Good communication between clinicians and psychologists 
- Psychologists can help with service development 
- Better liaison between local psychology team and 
community mental health services 
 
Specific training needs: 
- Training of health professionals in brief psychological 
interventions 
- Training of health professionals in identifying who would 











Quotes highlighting range of perceived benefits of having specialist 
psychological support embedded within teams  
 
- Patients with chronic condition require psychological support and 
ideally it should be offered and be available in routine practice; it 
would be highly effective to have psychologist working alongside us 
and providing support when needed (Consultant, Rheumatology, W 
Midlands) 
 
- We have an embedded counselling team in the renal unit for all 
patients and can access them this way (Consultant, Nephrology, 
London) 
 
- Need increased provision of clinical psychology, to help with service 
development, increased supervision and training, group support and 
increased provision of brief psychological support by other AHPs 
(AHP, SW England, Rheumatology) 
 
- Better liaison with local psychology team and with the community 
mental health services (Consultant, Rheumatology, SE England) 
 
- All Rheumatology health professionals should have training in how to 
provide some psychological support themselves (Specialist Nurse, 




    
  45 
 
  
Table 3. Key elements of self-management and psychological support for people with CTD and Vasculitis identified by rheumatology and nephrology 
health professionals in the UK. Mapped to the Chronic Care Model (B-F). B. Decision Support, D Patient self-management, E. Personal and Community 









Patient centred  
- Use agenda setting tool within clinic appointments 
- Engage with patients to understand psychological impact 
- Training health professionals on what support is available 
- Variety of options to suit different patients 
 
Evidence required 
- Understanding and prioritising main issues faced by 
patients (as a group) 
- Understanding how disease affects individual patients to 
support them better 
- Evidenced- based interventions to support self-
management 
- Interventions tailored with disease specific components 
 
 
Decision support requirements 
 
- Engage with patients and understand psychological impact due to 
their condition (Doctor, Rheumatology, NW England) 
 
- More variety of options to offer people who need help (not everyone 
responds to the same approach), better links with primary care to 
join up care and step-down support from hospital to community 
(Consultant, NE England, Rheumatology) 
 
- Develop a more comprehensive, structured approach, supported by 
evidence for demonstrably effective interventions (Consultant, 
Nephrology, Wales) 
 
- Tailoring more to disease specific components. Service design to 










to manage their 
health-related 
quality of life 
and health care 
 
Potential methods of support for self-management within 
secondary care  
- Specific self-management programmes for people with CTD 
and vasculitis 
- Opening-up generic self-management programmes 
- 1 to 1 self-management support 
- Written information 
- Online self-management programme 
 
Specific topics:  
- Managing pain 
- Managing fatigue 
 
Quotes related to self-management support in secondary care 
 
- The initial approaching of the patient and making him/her realise 
that their role is vital and empower them to take a leading role for 
certain aspects of their care (Consultant, W Midlands, 
Rheumatology) 
 
- We have a multi-disciplinary team who deliver self-management 
support for a wide range of Rheumatology conditions.  Self-
management support for patients with CTD/Vasculitis is offered on a 
1:1 basis at present, however we are looking into adapting our 
current ‘living well with arthritis’ programme to offer a more tailored 
15 
  
- Managing symptoms of disease 
- Guidance to patients on navigation through the NHS 
system 
programme to patients with CTD/vasculitis. (AHP, Rheumatology, SW 
England) 
 
E. Personal and 
Community 
resources           
Assets and 
resources 




Community resources – what is helpful? 
- Peer support 
- Local support groups 
- National patient charities 
- Online and written information 
 
Staff knowledge needed 
- Awareness of support options 
- How/where to signpost to for support 
 
 
Quotes related to accessing community resources 
 
- Online support via charities and mental health charities/NHS Choices 
anxiety and depression, Mind, Mindfulness, mood gym etc. 
(Specialist Nurse, Rheumatology, W Midlands). 
 
- We don't have a specialist nurse with an interest in vasculitis - I think 
this would help.  We do refer to a peer support group and web-based 
resources, but don't have specific written information (Consultant, 
Wales, Nephrology) 
 
- Patient centred team approach, knowledge of local services and 





system design                








Design of delivery systems to support people with CTD and 
vasculitis 
- Pathway for people with CTD/vasculitis 
- Timely access to services at diagnosis and during 
flare/rapid review 
- Advice line support 
- Continuity of care 
 
Multidisciplinary approach is important for people with CTD 
and vasculitis 
- Specialist nurse with interest in CTD/vasculitis to act as key 
contact for people 
- Access to occupation health, physiotherapy and 
psychological support when needed. 
- Embedded psychologist has multiple benefits 
 
 
Importance of service design 
 
- A pathway for patients with CTD/ vasculitis and making appropriate 
services available to all inflammatory rheumatic diseases rather than 
disease specific or just inflammatory arthritis. (Specialist Nurse, 
Rheumatology, SW England) 
-  
 
- [importance of] Specialist teams rather than individual clinicians, 
nurse specialist for vasculitis (Consultant, Nephrology, SW England) 
  
- Psychologists as part of the team. MDT approach facilitating a 
joined- up approach. Working with psychologists in group programs. 





Supplementary material A. Geographical distribution of participants. 
   
Geographical region N % 
Northern Ireland 1 1.0 
North East England 2 2.0 
North West England 10 9.8 
Yorkshire & Humberside 6 5.9 
East Midlands 9 8.8 
West Midlands 8 7.8 
Wales 3 2.9 
East England 10 9.8 
London 12 11.8 
South West England 24 23.5 
South East England 14 13.7 
Scotland 3 2.9 
Missing 19 18.6 
Total 102 100 
 
